bendeka.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-Agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | BENDEKA® (bendamustine HCl) injection | |
| Description | BENDEKA® (bendamustine HCl) Injection information for |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 45.60.171.76 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
bendeka.com Valuation
|
US$11,244,681
Last updated: 2023-05-10 12:46:32
bendeka.com has Semrush global rank of 941,272. bendeka.com has an estimated worth of US$ 11,244,681, based on its estimated Ads revenue. bendeka.com receives approximately 1,297,464 unique visitors each day. Its web server is located in United States, with IP address 45.60.171.76. According to SiteAdvisor, bendeka.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$11,244,681 |
| Daily Ads Revenue | US$10,380 |
| Monthly Ads Revenue | US$311,392 |
| Yearly Ads Revenue | US$3,736,694 |
| Daily Unique Visitors | 86,498 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| bendeka.com. | A | 7199 | IP: 45.60.171.76 |
| bendeka.com. | A | 7199 | IP: 45.60.151.76 |
| bendeka.com. | NS | 86400 | NS Record: ns4.tevapharm.com. |
| bendeka.com. | NS | 86400 | NS Record: ns5.tevapharm.com. |
| bendeka.com. | NS | 86400 | NS Record: ns3.tevapharm.com. |
| bendeka.com. | TXT | 86400 | TXT Record: _globalsign-domain-verification=-mrCDIV71wAl5ZEI_KNjAQkTP909CIi-uVPaygQrSE |
| bendeka.com. | TXT | 86400 | TXT Record: v=spf1 ~all |
HtmlToTextCheckTime:2023-05-10 12:46:32
| About BENDEKA Treatment with BENDEKA About CLL and NHL Taking BENDEKA What to expect from BENDEKA Side Effects Understanding serious side effects Understanding common side effects FAQs Support Assistance Resources For Healthcare Professionals Prescribing Information Important Safety Information Bendeka For Healthcare Professionals Prescribing Information Important Safety Information About BENDEKA Treatment with BENDEKA About CLL and NHL Taking BENDEKA What to expect from BENDEKA Side Effects Understanding serious side effects Understanding common side effects FAQs Support Assistance Resources BENDEKA is indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) — efficacy relative to first-line therapies other than chlorambucil has not been established — or patients with indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed during or within 6 months of treatment with rituximab or a rituximab-containing regimen. BENDEKA allows patients time off active |
HTTP Headers
HTTP/1.1 301 Moved Permanently Location: https://www.bendeka.com/ Content-Length: 0 Connection: close HTTP/2 200 cache-control: no-cache pragma: no-cache content-length: 25972 content-type: text/html; charset=utf-8 expires: -1 server: Microsoft-IIS/10.0 set-cookie: ASP.NET_SessionId=1lqupi0gbp0mkevtek3tcfga; path=/; HttpOnly; SameSite=Lax x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET arr-disable-session-affinity: true x-frame-options: DENY date: Tue, 02 Nov 2021 19:10:37 GMT set-cookie: visid_incap_2021471=Sy7srhYDRImP1bijDdV5cS2NgWEAAAAAQUIPAAAAAAAMuZsNLbJbRTo90hLIPPsa; expires=Wed, 02 Nov 2022 07:42:38 GMT; HttpOnly; path=/; Domain=.bendeka.com set-cookie: nlbi_2021471=WdTwLOVzwRsp2EuMAissEQAAAACK+nDtMkRTWz7uYmLDd3Wu; path=/; Domain=.bendeka.com set-cookie: incap_ses_8222_2021471=4aBFYBDxlx1huIm2l2kaci2NgWEAAAAA1xafuavCEXCMA+9ta37ABA==; path=/; Domain=.bendeka.com x-cdn: Imperva x-iinfo: 13-33081718-33081721 NNNN CT(51 80 0) RT(1635880237657 0) q(0 0 1 3) r(3 3) U6 |
bendeka.com Whois Information
Domain Name: BENDEKA.COM Registry Domain ID: 1917799180_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.comlaude.com Registrar URL: http://www.comlaude.com Updated Date: 2021-04-04T23:07:25Z Creation Date: 2015-04-09T14:43:00Z Registry Expiry Date: 2022-04-09T14:43:00Z Registrar: Nom-iq Ltd. dba COM LAUDE Registrar IANA ID: 470 Registrar Abuse Contact Email: abuse@comlaude.com Registrar Abuse Contact Phone: +442074218250 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS3.TEVAPHARM.COM Name Server: NS4.TEVAPHARM.COM Name Server: NS5.TEVAPHARM.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-23T09:27:56Z <<< |